Form 8-K - Current report:
SEC Accession No. 0001144204-15-037084
Filing Date
2015-06-15
Accepted
2015-06-15 09:00:42
Documents
3
Period of Report
2015-06-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v412881_8k.htm 8-K 15765
2 PRESS RELEASE v412881_ex99-1.htm EX-99.1 25347
3 GRAPHIC image_001.jpg GRAPHIC 3944
  Complete submission text file 0001144204-15-037084.txt   47868
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 15930337
SIC: 2834 Pharmaceutical Preparations